We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. markets closed

Sorrento Therapeutics, Inc. (SRNEQ)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0300+0.0010 (+3.45%)
At close: 03:52PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0290
Open0.0200
BidN/A x N/A
AskN/A x N/A
Day's Range0.0200 - 0.0310
52 Week Range0.0010 - 0.4190
Volume150,984
Avg. Volume372,429
Market Cap16.538M
Beta (5Y Monthly)2.29
PE Ratio (TTM)N/A
EPS (TTM)-1.1000
Earnings DateMay 13, 2024 - May 17, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SRNEQ

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Sorrento Therapeutics, Inc.
    DVAX: What does Argus have to say about DVAX?DYNAVAX TECHNOLOGIES CORP has an Investment Rating of SELL; a target price of $10.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more